CVS Health announced plans to separate into two independent publicly traded companies by the first half of 2028. One company will focus on healthcare solutions, including Aetna and CVS Caremark, while the other will be a retail pharmacy company with CVS pharmacies and MinuteClinic. The split aims to enhance focus, innovation, and value for stakeholders, with both companies expected to maintain strong financial profiles and investment-grade ratings. Shareholders will own shares in both companies, and the separation is intended to be tax-free. CVS Health will continue current operations until the split is completed.
CVS Health trades at USD 92.35 on Pluang as of Nov 04, 2026 18:41 WIB, up 1.03% in one day. The stock holds a market cap of $116.91 billion and a dividend yield of 2.91%. Investor interest is strong, with 91% of Pluang orders to buy CVS shares. This trading activity occurs while CVS plans its split into two companies by 2028.
CVS Health reported a 5.4% increase in third-quarter revenues to $108.4 billion, driven by growth in its Health Services and Health Care Benefits segments. GAAP diluted EPS improved to $1.68 from a loss of $3.13 last year, while adjusted EPS rose to ...
CVS Health will divide into two separate companies, separating its retail pharmacy business from its insurance and pharmacy-benefit operations. One company will keep the CVS Health name and be led by CEO David Joyner. This move reverses CVS's previou...
CVS Health and McDonald's are set to report earnings soon, with both stocks labeled 'too cheap to ignore' by Jim Cramer despite underlying risks. CVS has shown strong earnings growth and raised its full-year guidance, but faces potential policy risks...
